In this issue of Life Sciences Report you can readabout employees' right to compensation and the new agreement governing the area. It also provides an update on legislative changes to trademark law and how these will affect your registrations. We also summarise the statement issued by the Advocate General in the long-running dispute between Hoechst and Genentech regarding the obligation to pay royalties on a revoked patent. These are just some of the interesting articles in this latest edition of Life Sciences Report.
Our guestcontributors, Managing Director Mr. Johan Wallér and Chief Economist Mr. Johan Davidson from the Swedish Pharmacy Association, discuss the new Pharmacy Inquiry and the patient perspective. Please feel free to contact us at Setterwalls for a more in-depth look at these and other issues.